240-year-old drug could save UK NHS £100 million a year treating common heart rhythm disorder
A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...
Too Old to Operate9h
Digoxin Offers Cost Savings Over Beta-Blockers in AF Care
The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...
Daily13h
Abelacimab reduces ischemic Stroke Risk in Atrial Fibrillation Patients with fewer bleeding events: NEJM
Researchers have found in a new research that among patients with atrial fibrillation who are at moderate-to-high risk for ...
FOX 5 Atlanta on MSN4h
Mattie's Call: 87-year-old Marietta man with dementia missing
Authorities have issued a Mattie’s Call for 87-year-old John Elmer Eaton, who went missing on the morning of Jan. 30 after ...
Cobb County Police looking for missing 87-year-old with dementia | What we know
According to the Cobb County Police Department, officers responded to the Sewell Mill Road area at almost noon on Thursday ...
Medscape8h
Managing Hyperthyroidism in Older Adults
Thyroid disease is often missed in older adults because its symptoms overlap with those of “normal aging.” In this two-article series, we examine thyroid disorders in the elderly, beginning with ...
Stirling stroke woman offers blood pressure check advice after scare
Joan is now recovering from her stroke eight years ago - with doctors putting it down to high blood pressure and stress from ...
Bristol-Myers Squibb (NYSE:BMY) Price Target Raised to $65.00
Bristol-Myers Squibb (NYSE:BMY – Free Report) had its target price boosted by Citigroup from $60.00 to $65.00 in a report published on Tuesday,Benzinga reports. They currently have a neutral rating on ...
An easy addition to your morning routine could slash risk of strokes
The £50 high street eye test which can detect 12 health conditionsRegularly flossing could slash your risk of a stroke, a ...
Le Lézard8h
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...